Fabrazyme 35 MG Injection

RxCUI: 1804758
RxNorm name: Fabrazyme 35 MG Injection
Display name: Fabrazyme 35 MG Injection
Full name: Fabrazyme 35 MG Injection
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:09

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
103979	Fabrazyme	agalsidase beta	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Fabrazyme	AGALSIDASE BETA	Genzyme Corporation	988513ab-b06f-4dd0-93f7-d2d4531dcce4	2025-08-22	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 1804758

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
988513ab-b06f-4dd0-93f7-d2d4531dcce4	Fabrazyme 35 MG Injection	SY	35	These highlights do not include all the information needed to use FABRAZYME ® safely and effectively. See full prescribing information for FABRAZYME ® . FABRAZYME ® (agalsidase beta) for injection, for intravenous use Initial U.S. Approval: 2003	20250822
988513ab-b06f-4dd0-93f7-d2d4531dcce4	Fabrazyme 35 MG Injection	PSN	35	These highlights do not include all the information needed to use FABRAZYME ® safely and effectively. See full prescribing information for FABRAZYME ® . FABRAZYME ® (agalsidase beta) for injection, for intravenous use Initial U.S. Approval: 2003	20250822
988513ab-b06f-4dd0-93f7-d2d4531dcce4	agalsidase beta 35 MG Injection [Fabrazyme]	SBD	35	These highlights do not include all the information needed to use FABRAZYME ® safely and effectively. See full prescribing information for FABRAZYME ® . FABRAZYME ® (agalsidase beta) for injection, for intravenous use Initial U.S. Approval: 2003	20250822